#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema Narcolepsy Hepatoblastoma Pouchitis Synovial sarcoma Gastrointestinal disorder Congenital growth hormone deficiency Deafness bilateral Depression Immunodeficiency common variable Squamous cell carcinoma of head and neck T-cell lymphoma Biotinidase deficiency Kawasaki's disease Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Diagnostics Hereditary hypophosphataemic rickets – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information Synovial sarcoma metastatic – Basic Information Marfan’s syndrome Epidermolysis bullosa – Trials in Disease Gaucher’s disease type I – Life with Disease Gaucher’s disease type I – Trials in Disease Gaucher’s disease type I – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dsimc Fidanacogene Elaparvovec Mometasone Furoate Trehalose Dihydrate (Ph.eur.) Aaa802 [89ZR]ZR-DFO-CIT-013 Rbl016.2 Ponatinib Iomeprol GSK5764227 Tedizolid Phosphate Clebopride Hydrogen Maleate Resiquimod Sulfate Paclitaxel GSKVX000000030810 Tipapkinogene Sovacivec LUXDEGALUTAMIDE Istradefylline Mecasermin Rinfabate Prednisolone More therapies…

    Learn about Your Condition

    Polycythaemia vera Pyelonephritis Adenocarcinoma gastric Seizure Pain in extremity Erdheim-Chester disease Soft tissue sarcoma Rhabdoid tumour of the kidney Haemorrhage prophylaxis Pigmentary glaucoma Cortical dysplasia Immunosuppression Affective disorder Urethral valves Chronic hepatitis B More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

    Recruiting

    4 1 1
    Investigated Drugs:
    • Kyv-101
    Germany
  • Study of Dapansutrile and Paracetamol for Patients with Acute Gout Flare

    Recruiting

    4 1 1
    Investigated Drugs:
    • Dapansutrile
    • Paracetamol
    France The Netherlands Spain
  • Study on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1

    Recruiting

    2 1
    Investigated Drugs:
    • Vx-670
    Belgium France Germany Italy The Netherlands Spain
  • Effect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    • Osteoporosis
    Investigated Drugs:
    • Denosumab
    • Zoledronic Acid Monohydrate
    Italy
  • Randomized Placebo‑Controlled Trial of Colchicine to Slow Disease Progression in Adults with Amyotrophic Lateral Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Colchicine
    Italy
  • Early switch to oral amoxicillin (drug combination) for adults with vertebral osteomyelitis: a randomised non‑inferiority trial

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefalexin
    • Clindamycin
    • Flucloxacillin
    Germany
Previous Page
1 … 27 28 29 30 31 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!